Romagnoli C, Cataldi L, De Carolis M P, Zecca E, Luciano R, Tortorolo G
Pediatr Med Chir. 1983 Sep-Oct;5(5):305-10.
Phototherapy is largely used in the management of neonatal hyperbilirubinaemia, but its safety is very far from being proved. The Authors studied the effectiveness of daylight in low-birth-weight newborns. The results obtained show that the reduction of bilirubin induced by phototherapy is related with gestational age and intra-uterine growth. The very low-birth-weight infants, at higher risk of kernicterus, as they are more responsives to phototherapy, as well they are, probably, more susceptibles to side-effects. The Authors think that phototherapy should be planned on the basis of such observations.
光疗在新生儿高胆红素血症的治疗中广泛应用,但其安全性远未得到证实。作者研究了自然光对低体重新生儿的疗效。研究结果表明,光疗引起的胆红素降低与胎龄和宫内生长情况有关。极低体重儿发生核黄疸的风险较高,因为他们对光疗更敏感,而且可能更容易受到副作用的影响。作者认为应基于这些观察结果来制定光疗方案。